Kantar Media Healthcare Research
Which Pharma Companies Spent the Most in Print Journals in 2014?
In 2014, Johnson & Johnson spent more than $34 million advertising its drug products in professional health journals, meaning it comprises 6% of the total market share among all companies. 2014 was Johnson & Johnson's second year in a row as the top spender. Both AstraZeneca and GlaxoSmithKline are new to the top... Read More
The Top Drug Product Classes Advertising in Professional Health Journals in 2014
In 2014, print advertising dollars in professional health journals surpassed $606 million, a 2% increase year-over-year, according to Kantar Media. Antineoplastic Agents took the top spot as the most advertised product class with nearly $52 million spent. The top product classes by dollars are as follows: Top 5 Print Ad... Read More
2014's Most Advertised Drug Class in Medical Journals
There were 95,167 print advertising pages published in medical journals in 2014, a less-than-1% decrease year-over-year, according to Kantar Media. Antineoplastic agents (for cancer therapy) continue to be the top drug class advertising by both pages and dollars, as in both 2012 and 2013. Advertising pages for... Read More
Top Pharmaceuticals in 2014 by Ad Dollars Spent
Invokana, which treats type 2 Diabetes, is once again the top drug product advertised in medical journals by dollars in 2014. For the second year in a row, this product from Janssen Pharmaceuticals comprises about 3% of the total share among all drugs. Antidepressant Brintellix (manufactured by Takeda... Read More